AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
70.22
+1.49 (2.17%)
At close: Apr 14, 2026, 4:00 PM EDT
70.22
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:02 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
The 11 analysts that cover AnaptysBio stock have a consensus rating of "Buy" and an average price target of $74.64, which forecasts a 6.29% increase in the stock price over the next year. The lowest target is $20 and the highest is $100.
Price Target: $74.64 (+6.29%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AnaptysBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $67 → $95 | Buy | Maintains | $67 → $95 | +35.29% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | -6.01% | Mar 30, 2026 |
| UBS | UBS | Strong Buy Maintains $70 → $90 | Strong Buy | Maintains | $70 → $90 | +28.17% | Mar 17, 2026 |
| Wedbush | Wedbush | Buy Maintains $60 → $75 | Buy | Maintains | $60 → $75 | +6.81% | Mar 12, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $36 → $50 | Hold | Maintains | $36 → $50 | -28.80% | Mar 9, 2026 |
Financial Forecast
Revenue This Year
138.30M
from 234.60M
Decreased by -41.05%
Revenue Next Year
181.32M
from 138.30M
Increased by 31.11%
EPS This Year
-4.11
from -0.46
EPS Next Year
-4.33
from -4.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 158.6M | 247.8M | |||
| Avg | 138.3M | 181.3M | |||
| Low | 87.3M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -32.4% | 79.2% | |||
| Avg | -41.0% | 31.1% | |||
| Low | -62.8% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.15 | 0.09 | |||
| Avg | -4.11 | -4.33 | |||
| Low | -6.52 | -8.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.